...
search icon
pcrx-img

Pacira BioSciences, Inc., Common Stock

PCRX

NSQ

$24.65

+$0.18

(0.74%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.14B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.71
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$11.16 L
$31.67 H
$24.65

About Pacira BioSciences, Inc., Common Stock

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. The company has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FramePCRXSectorS&P500
1-Week Return4.05%0.44%0.24%
1-Month Return5.75%-7.69%-7.32%
3-Month Return10.24%-3.35%-12.05%
6-Month Return45.43%-11.09%-9.73%
1-Year Return-7.92%-2.13%5.05%
3-Year Return-66.23%-1.18%20.03%
5-Year Return-35.3%34.44%83.31%
10-Year Return-70.88%84.87%153.54%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue420.83M541.53M666.82M674.98M700.97M[{"date":"2020-12-31","value":60.04,"profit":true},{"date":"2021-12-31","value":77.26,"profit":true},{"date":"2022-12-31","value":95.13,"profit":true},{"date":"2023-12-31","value":96.29,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue117.33M140.25M199.29M184.67M170.43M[{"date":"2020-12-31","value":58.87,"profit":true},{"date":"2021-12-31","value":70.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.66,"profit":true},{"date":"2024-12-31","value":85.52,"profit":true}]
Gross Profit303.50M401.28M467.53M490.31M700.97M[{"date":"2020-12-31","value":43.3,"profit":true},{"date":"2021-12-31","value":57.25,"profit":true},{"date":"2022-12-31","value":66.7,"profit":true},{"date":"2023-12-31","value":69.95,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin72.12%74.10%70.11%72.64%100.00%[{"date":"2020-12-31","value":72.12,"profit":true},{"date":"2021-12-31","value":74.1,"profit":true},{"date":"2022-12-31","value":70.11,"profit":true},{"date":"2023-12-31","value":72.64,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses260.80M268.44M396.60M402.63M774.34M[{"date":"2020-12-31","value":33.68,"profit":true},{"date":"2021-12-31","value":34.67,"profit":true},{"date":"2022-12-31","value":51.22,"profit":true},{"date":"2023-12-31","value":52,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income46.35M131.06M60.02M87.67M(73.37M)[{"date":"2020-12-31","value":35.36,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":45.8,"profit":true},{"date":"2023-12-31","value":66.89,"profit":true},{"date":"2024-12-31","value":-55.98,"profit":false}]
Total Non-Operating Income/Expense(47.30M)(64.37M)(82.16M)(43.13M)13.38M[{"date":"2020-12-31","value":-353.4,"profit":false},{"date":"2021-12-31","value":-480.94,"profit":false},{"date":"2022-12-31","value":-613.79,"profit":false},{"date":"2023-12-31","value":-322.22,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income20.09M56.40M13.30M61.70M(63.11M)[{"date":"2020-12-31","value":32.56,"profit":true},{"date":"2021-12-31","value":91.42,"profit":true},{"date":"2022-12-31","value":21.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-102.28,"profit":false}]
Income Taxes(125.43M)14.42M(2.61M)19.75M36.45M[{"date":"2020-12-31","value":-344.09,"profit":false},{"date":"2021-12-31","value":39.57,"profit":true},{"date":"2022-12-31","value":-7.15,"profit":false},{"date":"2023-12-31","value":54.17,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes145.52M41.98M15.91M41.95M(99.56M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":28.85,"profit":true},{"date":"2022-12-31","value":10.93,"profit":true},{"date":"2023-12-31","value":28.83,"profit":true},{"date":"2024-12-31","value":-68.42,"profit":false}]
Income From Continuous Operations145.52M41.98M15.91M6.98M(99.56M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":28.85,"profit":true},{"date":"2022-12-31","value":10.93,"profit":true},{"date":"2023-12-31","value":4.8,"profit":true},{"date":"2024-12-31","value":-68.42,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income145.52M41.98M15.91M41.95M(99.56M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":28.85,"profit":true},{"date":"2022-12-31","value":10.93,"profit":true},{"date":"2023-12-31","value":28.83,"profit":true},{"date":"2024-12-31","value":-68.42,"profit":false}]
EPS (Diluted)2.202.992.592.923.21[{"date":"2020-12-31","value":68.54,"profit":true},{"date":"2021-12-31","value":93.15,"profit":true},{"date":"2022-12-31","value":80.69,"profit":true},{"date":"2023-12-31","value":90.97,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PCRX
Cash Ratio 1.56
Current Ratio 2.40
Quick Ratio 2.00

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PCRX
ROA (LTM) 3.90%
ROE (LTM) -12.08%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PCRX
Debt Ratio Lower is generally better. Negative is bad. 0.50
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.50

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PCRX
Trailing PE NM
Forward PE 8.94
P/S (TTM) 1.63
P/B 1.45
Price/FCF 37
EV/R 1.84
EV/Ebitda 44.19
PEG NM

FAQs

What is Pacira BioSciences, Inc. share price today?

Pacira BioSciences, Inc. (PCRX) share price today is $24.65

Can Indians buy Pacira BioSciences, Inc. shares?

Yes, Indians can buy shares of Pacira BioSciences, Inc. (PCRX) on Vested. To buy Pacira BioSciences, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PCRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Pacira BioSciences, Inc. be purchased?

Yes, you can purchase fractional shares of Pacira BioSciences, Inc. (PCRX) via the Vested app. You can start investing in Pacira BioSciences, Inc. (PCRX) with a minimum investment of $1.

How to invest in Pacira BioSciences, Inc. shares from India?

You can invest in shares of Pacira BioSciences, Inc. (PCRX) via Vested in three simple steps:

  • Click on Sign Up or Invest in PCRX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Pacira BioSciences, Inc. shares
What is Pacira BioSciences, Inc. 52-week high and low stock price?

The 52-week high price of Pacira BioSciences, Inc. (PCRX) is $31.67. The 52-week low price of Pacira BioSciences, Inc. (PCRX) is $11.16.

What is Pacira BioSciences, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Pacira BioSciences, Inc. (PCRX) is 1.45

What is the Market Cap of Pacira BioSciences, Inc.?

The market capitalization of Pacira BioSciences, Inc. (PCRX) is $1.14B

What is Pacira BioSciences, Inc.’s stock symbol?

The stock symbol (or ticker) of Pacira BioSciences, Inc. is PCRX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top